Urologic oncology.

ISSN 1078-1439Elsevier Inc.United States
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Journal identity
Titles
Urologic Oncology: Seminars and Original Investigations
Urol. Oncol. Semin. Orig. Invest. (abbreviated)
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS ELSEVIER SCIENCE INC
Urologic oncology.
Urol Oncol (abbreviated)
Key identifiers
ISSN
1078-1439
1078-1439
eISSN
1873-2496
NLM ID
9805460
Publisher / basic metadata
Publisher
Elsevier Inc.
New York, NY : Elsevier Science,
Country
Language
English
ENG

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
1995–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20252.3Q27030JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.997
Best Quartile
Q1
H-index
93
Subject categories (quartile varies by category)
  • Urology — Q1
  • Oncology — Q2
More metrics
Coverage
1995–2026
Country
United States
Region
Northern America
Publisher
Elsevier Inc.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
330
Total documents (3 years)
813
Total references
10030
Total citations (3 years)
2001
Citable documents (3 years)
790
Citations per document (2 years)
2.45
References per document
30.39
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1078-1439, 1873-2496
SCImago Source ID
13205
SCImago Rank (across all SCImago source types)
4936

Publication activity

Publication activity
SCImago
2025
330 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Genital Neoplasms, Male; Urologic Neoplasms
Coverage / history
Scopus:1995-2026
MEDLINE:MEDLINE: v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-; Index medicusIn: PubMed: v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-;
PubMed:MEDLINE: v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-; Index medicusIn: PubMed: v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-;